An Observational Study of Patients With Chronic Liver Disease

ID#: NCT05744713

Age: 18 years - 66+

Gender: All

Healthy Subjects: No

Recruitment Status: Enrolling by invitation

Start Date: February 19, 2024

End Date: December 31, 2037

Summary: TARGET-Liver Disease (TARGET-LD) is an observational research study to conduct a comprehensive review of outcomes for patients with chronic liver disease (CLD).
Eligibility:

Inclusion Criteria: Disease Cohort •Adult* patients at the time of enrollment with a diagnosis of CLD/cirrhosis by ICD-10 code in the EHR interface Engaged Cohort

- Adult* patients diagnosed and managed for CLD/cirrhosis invited to participate

- Ability to provide written informed consent

Exclusion Criteria: Disease Cohort

- Death

- Manual removal (sponsor or site request)

- No EHR interface encounter > 3 years. Engaged Cohort

- Patient expressed desire to withdraw consent to complete PROs

- Failure to complete PROs within 24 weeks of initial invitation

- Greater than 24 months lapse of survey completion after baseline surveys completed

- Additionally, the criteria detailed for Disease Cohort apply to the Engaged Cohort.
Find a Clinical Trial Find Cancer Clinical Trials